Bereich
Medizinische Onkologie und Hämatologie
ONKO · Dept. I
The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas
Laurencet F, Zulian G, Plancherel C, Luthi J, Fey M, Cerny T, Hess U, Rufener B, Ballabeni P, Swiss Group for Clinical Research (SAKK). The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas. Acta haematologica 2007; 117:40-7.
01.01.2007The multicenter trial SAKK 37/95 of cladribine, cyclophosphamide and prednisone in the treatment of chronic lymphocytic leukemias and low-grade non-Hodgkin's lymphomas
01.01.2007Acta haematologica 2007; 117:40-7
Laurencet France, Zulian Gilbert B, Plancherel Catherine, Luthi Jean-Marc, Fey Martin, Cerny Thomas, Hess Urs, Rufener Beatrice, Ballabeni Pierluigi, Swiss Group for Clinical Research (SAKK)
Pegylated liposomal doxorubicin (caelyx) in metastatic breast cancer: a community-based observation study
Salzberg M, Thürlimann B, Hasler U, Delmore G, von Rohr A, Thurlimann A, Ruhstaller T, Stopatschinskaja S, von Moos R. Pegylated liposomal doxorubicin (caelyx) in metastatic breast cancer: a community-based observation study. Oncology 2007; 72:147-51.
01.01.2007Pegylated liposomal doxorubicin (caelyx) in metastatic breast cancer: a community-based observation study
01.01.2007Oncology 2007; 72:147-51
Salzberg Marc, Thürlimann Beat, Hasler Ursula, Delmore Geoffrey, von Rohr Albert, Thurlimann Annatina, Ruhstaller Thomas, Stopatschinskaja Shanna, von Moos Roger
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
Perey L, Goldhirsch A, Köberle D, Clément P, Dietrich D, Fiche M, Wildiers H, Nolé F, Zaman K, Hawle H, Paridaens R, Thürlimann B. Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00). Ann Oncol 2007; 18:64-9.
01.01.2007Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
01.01.2007Ann Oncol 2007; 18:64-9
Perey L, Goldhirsch A, Köberle Dieter, Clément P, Dietrich D, Fiche M, Wildiers H, Nolé F, Zaman K, Hawle H, Paridaens R, Thürlimann Beat
Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
Köberle D, Thürlimann B. Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98. Breast Cancer Res Treat 2007; 105 Suppl 1:55-66.
01.01.2007Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
01.01.2007Breast Cancer Res Treat 2007; 105 Suppl 1:55-66
Köberle Dieter, Thürlimann Beat
Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations
Thürlimann B, Köberle D, Senn H. Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations. EJC 2007; 43:46-52.
01.01.2007Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations
01.01.2007EJC 2007; 43:46-52
Thürlimann Beat, Köberle Dieter, Senn Hans-Joerg
Die Primärbehandlung des frühen Mammakarzinoms
Kapp U, Fürstenberger G, Thürlimann B. Die Primärbehandlung des frühen Mammakarzinoms - Internationale St. Gallen-Konsensus Konferenz 2007. Schweizer Zeitschrift für Onkologie 2007; 4:6-10.
01.01.2007Die Primärbehandlung des frühen Mammakarzinoms
01.01.2007Schweizer Zeitschrift für Onkologie 2007; 4:6-10
Kapp U, Fürstenberger G, Thürlimann Beat
Brustzentren in der Schweiz
Thürlimann B. Brustzentren in der Schweiz. Schweizer Zeitschrift für Onkologie 2007; 4:22-23.
01.01.2007Brustzentren in der Schweiz
01.01.2007Schweizer Zeitschrift für Onkologie 2007; 4:22-23
Thürlimann Beat
Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis
Vehoff J, Hundsberger T, Hitz F, Tettenborn B (2007). Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis.
01.01.2007Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis
01.01.2007-
Vehoff Jochen, Hundsberger Thomas, Hitz F, Tettenborn Barbara
L-Dopa responsive movement disorder in a young patient with mixed connective tissue disease (sharp syndrome)
Hägele-Link S, Burow A, Hundsberger T, Tettenborn B (2007). L-Dopa responsive movement disorder in a young patient with mixed connective tissue disease (sharp syndrome).
01.01.2007L-Dopa responsive movement disorder in a young patient with mixed connective tissue disease (sharp syndrome)
01.01.2007-
Hägele-Link Stefan, Burow A, Hundsberger Thomas, Tettenborn Barbara
Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole
Krauss K, Bachmann C, Hartmann J, Siegmann K, Sotlar K, Wallwiener D, Huober J. Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole. Anticancer research 2007; 27:3477-80.
01.01.2007Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole
01.01.2007Anticancer research 2007; 27:3477-80
Krauss K, Bachmann C, Hartmann J T, Siegmann K, Sotlar K, Wallwiener D, Huober Jens
Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
Waeckerle-Men Y, Groettrup M, Ludewig B, Cerny T, Ackermann D, Schmid H, Böhme C, von Moos R, Fopp M, Uetz-von Allmen E, Gillessen Sommer S. Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma. Cancer immunology, immunotherapy : CII 2006; 55:1524-33.
01.12.2006Dendritic cell-based multi-epitope immunotherapy of hormone-refractory prostate carcinoma
01.12.2006Cancer immunology, immunotherapy : CII 2006; 55:1524-33
Waeckerle-Men Ying, Groettrup Marcus, Ludewig Burkhard, Cerny Thomas, Ackermann Daniel, Schmid Hans-Peter, Böhme Christel, von Moos Roger, Fopp Markus, Uetz-von Allmen Edith, Gillessen Sommer Silke
Spirituelle Erfahrungen in Leid und Sterben
Renz M. Spirituelle Erfahrungen in Leid und Sterben. Theologie aktuell 2006; 21:32-34.
01.12.2006Spirituelle Erfahrungen in Leid und Sterben
01.12.2006Theologie aktuell 2006; 21:32-34
Renz Monika
First--select the target: better choice of adjuvant treatments for breast cancer patients
Goldhirsch A, Coates A, Gelber R, Glick J, Thürlimann B, Senn H, St Gallen Expert Panel Members. First--select the target: better choice of adjuvant treatments for breast cancer patients. Ann Oncol 2006; 17:1772-6.
01.12.2006First--select the target: better choice of adjuvant treatments for breast cancer patients
01.12.2006Ann Oncol 2006; 17:1772-6
Goldhirsch A, Coates A S, Gelber R D, Glick J H, Thürlimann Beat, Senn H-J, St Gallen Expert Panel Members
Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial
Harter P, Emons G, Pfisterer J, Wollschlaeger K, Meerpohl H, Breitbach G, Tanner B, Sehouli J, Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Committee, Schmalfeldt B, Muenstedt K, Schröder W, du Bois A, Hahmann M, Hasenburg A, Burges A, Loibl S, Gropp M, Huober J, Fink D, AGO Ovarian Cancer Study Group. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Annals of surgical oncology 2006; 13:1702-10.
01.12.2006Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial
01.12.2006Annals of surgical oncology 2006; 13:1702-10
Harter Philipp, Emons Guenter, Pfisterer Jacobus, Wollschlaeger Kerstin, Meerpohl Hans-Gerd, Breitbach Georg-Peter, Tanner Berno, Sehouli Jalid, Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Committee, Schmalfeldt Barbara, Muenstedt Karsten, Schröder Willibald, du Bois Andreas, Hahmann Maik, Hasenburg Annette, Burges Alexander, Loibl Sibylle, Gropp Martina, Huober Jens, Fink Daniel, AGO Ovarian Cancer Study Group
Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies
Leyvraz S, Pestalozzi B, Dietrich D, Cerny T, Wernli M, Sessa C, Fey M, Christinat A, Honegger H, Guillou L, Herrmann R, Swiss Group for Clinical Cancer Research (SAKK). Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies. British journal of cancer 2006; 95:1342-7.
20.11.2006Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies
20.11.2006British journal of cancer 2006; 95:1342-7
Leyvraz S, Pestalozzi B, Dietrich D, Cerny Thomas, Wernli M, Sessa C, Fey M F, Christinat A, Honegger H P, Guillou L, Herrmann R, Swiss Group for Clinical Cancer Research (SAKK)
Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma
Schlaeppi M, Korte W, von Moos R, Cerny T, Gillessen Sommer S. Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma. Onkologie 2006; 29:531-3.
01.11.2006Successful treatment of acute disseminated intravascular coagulation in a patient with metastatic melanoma
01.11.2006Onkologie 2006; 29:531-3
Schlaeppi Marc, Korte Wolfgang, von Moos Roger, Cerny Thomas, Gillessen Sommer Silke
Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis
Langenegger T, Wahl P, Schiesser D, Thürlimann B. Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis. Breast Cancer Res Treat 2006; 100:177-81.
01.11.2006Plasma levels of tamoxifen, N-desmethyl tamoxifen and anastrozole in a patient with metastatic breast cancer and chronic hemodialysis
01.11.2006Breast Cancer Res Treat 2006; 100:177-81
Langenegger T, Wahl P, Schiesser D, Thürlimann Beat
National trends in health care utilization and racial and socioeconomic disparities in pediatric pyogenic arthritis
Freedman J, Gueller U, Benjamin D, Higgins L, Pan D, Cook C, Pietrobon R. National trends in health care utilization and racial and socioeconomic disparities in pediatric pyogenic arthritis. J Pediatr Orthop 2006; 26:709-15.
01.11.2006National trends in health care utilization and racial and socioeconomic disparities in pediatric pyogenic arthritis
01.11.2006J Pediatr Orthop 2006; 26:709-15
Freedman Josh, Gueller Ulrich, Benjamin Daniel Kelly, Higgins Laurence D, Pan Deng, Cook Chad, Pietrobon Ricardo
Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial.
Maggiorini M, Brunner-La Rocca H, Peth S, Fischler M, Böhm T, Bernheim A, Kiencke S, Bloch K, Dehnert C, Naeije R, Lehmann T, Bärtsch P, Mairbäurl H. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial. Ann Intern Med 2006; 145:497-506.
03.10.2006Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial.
03.10.2006Ann Intern Med 2006; 145:497-506
Maggiorini Marco, Brunner-La Rocca Hans-Peter, Peth Simon, Fischler Manuel, Böhm Thomas, Bernheim Alain, Kiencke Stefanie, Bloch Konrad E, Dehnert Christoph, Naeije Robert, Lehmann Thomas, Bärtsch Peter, Mairbäurl Heimo
Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain
Rückrich T, Driessen C, Reich M, Melms A, Beck A, Wiederanders B, Schilling K, Stevanovic S, Müller M, Cansier A, Brandenburg J, Kalbacher H. Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain. Biol Chem 2006; 387:1503-11.
01.10.2006Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain
01.10.2006Biol Chem 2006; 387:1503-11
Rückrich Thomas, Driessen Christoph, Reich Michael, Melms Arthur, Beck Alexander, Wiederanders Bernd, Schilling Klaus, Stevanovic Stefan, Müller Margret, Cansier Alexander, Brandenburg Jens, Kalbacher Hubert